New Devyser BRCA NGS study published

Hereditary cancer

Hereditary cancer | September 30, 2022

Check out a recent publication from Capone et al from the University of Florence!

In this study, the Devyser BRCA test was used to analyze 227 patient DNA samples. They concluded that 100% of the expected SNVS and CNVS were detected and that the single-tube PCR-based library preparation format of the kit offers a decrease in processing time as well as a reduced risk of cross-contamination.

Read abstract using this link

Contact an expert at Devyser

If you have a question, feel free to send us a message. One of our team members will get in touch with you as soon as possible.

New Devyser BRCA NGS study published

Contact an expert at Devyser

Devyser at 20: Celebrating two decades of innovation in genetic diagnostics

Devyser seeks to secure FDA approval for NGS test for kidney transplant monitoring

Devyser Compact achieves Class III approval in China

Devyser to share data at ASHI 2024 demonstrating its innovations and studies within transplantation

New Devyser BRCA NGS study published

Contact an expert at Devyser

Related Articles

Devyser at 20: Celebrating two decades of innovation in genetic diagnostics

Devyser seeks to secure FDA approval for NGS test for kidney transplant monitoring

Devyser Compact achieves Class III approval in China

Devyser to share data at ASHI 2024 demonstrating its innovations and studies within transplantation